Kellerhals Carrard advises GETEC on Rhine Valley Park acquisition
Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland, the platform of a leading European energy supplier and contracting specialist GETEC Group. They are the new owner and operator of the properties and infrastructure facilities of the Life-Science-Park and takes over employees working in these areas from the previous owner, Novartis.
The Life-Science-Park Rhine Valley is located in Stein, Aargau, and is part of the “Sisslerfeld” development focus in the canton of Aargau with an estimate of between 10,000 and 15,000 people employed there by 2040. GETEC Switzerland intends to use the park’s great potential to attract more businesses and to expand the services ad workforce for the park’s operation contributing to the further economic development of the region. The acquisition is expected to be completed before the end of the year. The purchase price was not disclosed.
Kellerhals Carrard acted as legal advisor to GETEC Switzerland on this transaction. The team was co-led by managing partner Nicolas Mosimann (pictured left) and partner Marc Hanslin (pictured right; both corporate/m&a) and comprised Sophie Holdt, Marius Gröteke, Anna Laishevtseva, Jan Borer and Alessandro Samà (all corporate/m&a), Philipp A. d’Hondt and Livio Marelli (both real estate), Isabelle Romy and Denise Wohlwend (both environment), Christoph Jäger, Susanna Baumgartner, Thomas Geiger, Gregor Bachmann (all regulatory), Daniel Emch (anti-trust), Marco Sibold (taxes), Milena Grob (operations), Daniel Staehelin (insolvency) as well as Pascal Grolimund (insurance).
Homburger advised Novartis alongside Freshfields Bruckhaus Deringer on the Swiss law and tax aspects of the transaction. The team was led by Daniel Häusermann (pictured bottom; corporate / m&a, real estate) and includes Olivier Bühlmann, Daniel Kuhn (both corporate / m&a, real estate), Stefan Gäumann (real estate), Oriana Schöni (corporate / m&a), Reto Heuberger, Peter Müller and Philippe Weber (all tax), Jürg Frick (financing and Investment Products), Gregor Bühler and Marc Bircher (both employment), Andri Hess (IP / IT, Healthcare / Life Sciences), Allegra Arnold and Katharina Bratvogel (both competition, regulatory), as well as other professionals.
